{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:52:40Z","timestamp":1773964360398,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Patients with neurologic diseases often have neurogenic detrusor overactivity (NDO), which can result in a loss of voluntary bladder control and uncontrollable urinary incontinence (UI).The impact of UI due to NDO on patients\u2019 lives has not been well studied. The objective of this review was to assess the health-related quality of life (HRQoL) and economic burden in patients with urgency UI due to NDO in select countries in North America, the European Union, Asia, and Australia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Systematic literature searches and reviews of articles published in English (January 2000 to February 2011) were conducted using MEDLINE\u00ae, EMBASE\u00ae, and the Cochrane Library. Studies assessing the impact of UI on HRQoL of patients with an underlying neurologic condition of interest (i.e., multiple sclerosis, spinal cord injury, Parkinson\u2019s disease, stroke, or spina bifida) were included. Economic studies in urgency UI also were included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of 876 citations generated in the initial search, a total of 27 articles were deemed relevant: 16 articles presented HRQoL data and 11 articles presented information on the economic burden of UI. Humanistic studies used a range of HRQoL instruments to measure HRQoL burden, and the economic studies included different cost components to quantify the economic burden, making meaningful comparisons challenging. Despite this heterogeneity, the literature suggests that HRQoL in patients with UI due to NDO is worse than patients with UI in general or those with the same underlying neurologic condition without UI. In addition, urgency UI also results in substantial economic costs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Incontinent patients with underlying neurologic conditions have impaired HRQoL as well as substantial economic burden attributable to UI due to NDO. There is a need for urgency UI treatments that improve HRQoL of these patients and alleviate the economic burden of this condition.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7525-11-13","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T21:13:56Z","timestamp":1359666836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Health-related quality of life and economic impact of urinary incontinence due to detrusor overactivity associated with a neurologic condition: a systematic review"],"prefix":"10.1186","volume":"11","author":[{"given":"Crisanta I","family":"Tapia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Khalaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Berenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Globe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Chancellor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley K","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,31]]},"reference":[{"key":"1083_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/nau.20870","volume":"29","author":"P Abrams","year":"2010","unstructured":"Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, Cottenden A, Davila W, de Ridder D, Dmochowski R: Fourth International consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 2010, 29: 213\u2013240. 10.1002\/nau.20870","journal-title":"Neurourol Urodyn"},{"key":"1083_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/nau.21003","volume":"30","author":"A Manack","year":"2011","unstructured":"Manack A, Motsko SP, Haag-Molkenteller C, Dmochowski RR, Goehring EL Jr, Nguyen-Khoa BA, Jones JK: Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol Urodyn 2011, 30: 395\u2013401. 10.1002\/nau.21003","journal-title":"Neurourol Urodyn"},{"key":"1083_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0378-5122(95)00982-5","volume":"23","author":"C Johansson","year":"1996","unstructured":"Johansson C, Molander U, Milsom I, Ekelund P: Association between urinary incontinence and urinary tract infections, and fractures in postmenopausal women. Maturitas 1996, 23: 265\u2013271. 10.1016\/0378-5122(95)00982-5","journal-title":"Maturitas"},{"key":"1083_CR4","first-page":"S598","volume":"8","author":"TH Wagner","year":"2002","unstructured":"Wagner TH, Hu TW, Bentkover J, LeBlanc K, Stewart W, Corey R, Zhou Z, Hunt T: Health-related consequences of overactive bladder. Am J Managed Care 2002, 8: S598\u2013607.","journal-title":"Am J Managed Care"},{"key":"1083_CR5","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1007\/s00415-005-0855-3","volume":"252","author":"Y Balash","year":"2005","unstructured":"Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N: Falls in outpatients with Parkinson\u2019s disease: frequency, impact and identifying factors. J Neurol 2005, 252: 1310\u20131315. 10.1007\/s00415-005-0855-3","journal-title":"J Neurol"},{"key":"1083_CR6","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/j.juro.2007.08.006","volume":"178","author":"SE Harpe","year":"2007","unstructured":"Harpe SE, Szeinbach SL, Caswell RJ, Corey R, McAuley JW: The relative importance of health related quality of life and prescription insurance coverage in the decision to pharmacologically manage symptoms of overactive bladder. J Urol 2007, 178: 2532\u20132536. discussion 2536 10.1016\/j.juro.2007.08.006","journal-title":"J Urol"},{"key":"1083_CR7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"WF Stewart","year":"2003","unstructured":"Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, Hunt TL, Wein AJ: Prevalence and burden of overactive bladder in the United States. World J Urol 2003, 20: 327\u2013336.","journal-title":"World J Urol"},{"key":"1083_CR8","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, Coyne K, Kelleher C, Hampel C, Artibani W, Abrams P: Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006, 50: 1306\u20131314. discussion 1314\u20131305 10.1016\/j.eururo.2006.09.019","journal-title":"Eur Urol"},{"key":"1083_CR9","unstructured":"The Oxford 2011 levels of evidence. http:\/\/www.cebm.net\/index.aspx?o=5653"},{"key":"1083_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/jnnp.56.3.245","volume":"56","author":"CD Betts","year":"1993","unstructured":"Betts CD, D\u2019Mellow MT, Fowler CJ: Urinary symptoms and the neurological features of bladder dysfunction in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993, 56: 245\u2013250. 10.1136\/jnnp.56.3.245","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1083_CR11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0022-5347(17)43390-8","volume":"138","author":"Y Berger","year":"1987","unstructured":"Berger Y, Blaivas JG, DeLaRocha ER, Salinas JM: Urodynamic findings in Parkinson\u2019s disease. J Urol 1987, 138: 836\u2013838.","journal-title":"J Urol"},{"key":"1083_CR12","unstructured":"Consumer Price Index. http:\/\/www.bls.gov\/cpi\/"},{"key":"1083_CR13","unstructured":"Consumer Prices. http:\/\/stats.oecd.org\/Index.aspx?DataSetCode=MEI_PRICES"},{"key":"1083_CR14","unstructured":"fxHistory\u00a9 Classic: Historical Currency Conversion Rates. http:\/\/www.oanda.com\/currency\/historical-rates-classic?srccont=rightnav"},{"key":"1083_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00345-009-0466-1","volume":"28","author":"B Wefer","year":"2010","unstructured":"Wefer B, Ehlken B, Bremer J, Burgdorfer H, Domurath B, Hampel C, Kutzenberger J, Seif C, Sievert KD, Berger K, Pannek J: Treatment outcomes and resource use of patients with neurogenic detrusor overactivity receiving botulinum toxin A (BOTOX) therapy in Germany. World J Urol 2010, 28: 385\u2013390. 10.1007\/s00345-009-0466-1","journal-title":"World J Urol"},{"key":"1083_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1191\/0269215506cr880oa","volume":"20","author":"A Forbes","year":"2006","unstructured":"Forbes A, While A, Mathes L, Griffiths P: Health problems and health-related quality of life in people with multiple sclerosis. Clin Rehabil 2006, 20: 67\u201378. 10.1191\/0269215506cr880oa","journal-title":"Clin Rehabil"},{"key":"1083_CR17","first-page":"277","volume":"26","author":"S Goris","year":"2010","unstructured":"Goris S, Sungur G, Tasci S, Mirza M, Ceyhan O, Tekinsoy P: The effect of urinary incontinence and sexual dysfunction on the quality of life among women with multiple sclerosis. Pak J Med Sci 2010, 26: 277\u2013281.","journal-title":"Pak J Med Sci"},{"key":"1083_CR18","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1080\/09638280802639566","volume":"31","author":"F Khan","year":"2009","unstructured":"Khan F, Pallant JF, Shea TL: Multiple sclerosis: prevalence and factors impacting bladder and bowel function in an Australian community cohort. Disabil Rehabil 2009, 31: 1567\u20131576. 10.1080\/09638280802639566","journal-title":"Disabil Rehabil"},{"key":"1083_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00192-006-0131-9","volume":"18","author":"G Quarto","year":"2007","unstructured":"Quarto G, Autorino R, Gallo A, De Sio M, D\u2019Armiento M, Perdon\u00e0 S, Damiano R: Quality of life in women with multiple sclerosis and overactive bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct 2007, 18: 189\u2013194.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"1083_CR20","volume-title":"User\u2019s Manual for the SF-36v2\u2122 Health Survey","author":"JE Ware Jr","year":"2007","unstructured":"Ware JE Jr, Kosinski M, Bjorner JB, Turner-Bowker DM, Maruish ME: User\u2019s Manual for the SF-36v2\u2122 Health Survey. 2nd edition. Lincoln, RI, USA: QualityMetric; 2007.","edition":"2"},{"key":"1083_CR21","volume-title":"Spinal Cord","author":"CW Liu","year":"2010","unstructured":"Liu CW, Attar KH: The relationship between bladder management and health-related quality of life in pts with spinal cord injury in the UK. Spinal Cord 2010., 48:"},{"key":"1083_CR22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.urology.2004.09.032","volume":"65","author":"SJ Oh","year":"2005","unstructured":"Oh SJ, Ku JH, Jeon HG, Shin HI, Paik NJ, Yoo T: Health-related quality of life of patients using clean intermittent catheterization for neurogenic bladder secondary to spinal cord injury. Urology 2005, 65: 306\u2013310. 10.1016\/j.urology.2004.09.032","journal-title":"Urology"},{"key":"1083_CR23","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s11136-010-9590-z","volume":"19","author":"W Hollingworth","year":"2010","unstructured":"Hollingworth W, Campbell JD, Kowalski J, Ravelo A, Girod I, Briggs A, Sullivan SD: Exploring the impact of changes in neurogenic urinary incontinence frequency and condition-specific quality of life on preference-based outcomes. Qual Life Res 2010, 19: 323\u2013331. 10.1007\/s11136-010-9590-z","journal-title":"Qual Life Res"},{"key":"1083_CR24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1080\/09638280500404362","volume":"28","author":"K Valtonen","year":"2006","unstructured":"Valtonen K, Karlsson AK, Siosteen A, Dahlof LG, Viikari-Juntura E: Satisfaction with sexual life among persons with traumatic spinal cord injury and meningomyelocele. Disabil Rehabil 2006, 28: 965\u2013976. 10.1080\/09638280500404362","journal-title":"Disabil Rehabil"},{"key":"1083_CR25","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/mds.23093","volume":"25","author":"E Iacovelli","year":"2010","unstructured":"Iacovelli E, Gilio F, Meco G, Fattapposta F, Vanacore N, Brusa L, Giacomelli E, Gabriele M, Rubino A, Locuratolo N: Bladder symptoms assessed with overactive bladder questionnaire in Parkinson\u2019s disease. Mov Disord 2010, 25: 1203\u20131209. 10.1002\/mds.23093","journal-title":"Mov Disord"},{"key":"1083_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.archger.2008.11.006","volume":"49","author":"SL Pohar","year":"2009","unstructured":"Pohar SL, Allyson Jones C: The burden of Parkinson disease (PD) and concomitant comorbidities. Arch Gerontol Geriatr 2009, 49: 317\u2013321. 10.1016\/j.archger.2008.11.006","journal-title":"Arch Gerontol Geriatr"},{"key":"1083_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/nau.20199","volume":"25","author":"DF Edwards","year":"2006","unstructured":"Edwards DF, Hahn M, Dromerick A: Post stroke urinary loss, incontinence and life satisfaction: when does post-stroke urinary loss become incontinence? Neurourol Urodyn 2006, 25: 39\u201345. 10.1002\/nau.20199","journal-title":"Neurourol Urodyn"},{"key":"1083_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3109\/00365590903013919","volume":"43","author":"S Tibaek","year":"2009","unstructured":"Tibaek S, Gard G, Klarskov P, Iversen HK, Dehlendorff C, Jensen R: Are activity limitations associated with lower urinary tract symptoms in stroke patients? A cross-sectional, clinical survey. Scand J Urol Nephrol 2009, 43: 383\u2013389. 10.3109\/00365590903013919","journal-title":"Scand J Urol Nephrol"},{"key":"1083_CR29","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1002\/nau.10114","volume":"22","author":"PL Kolominsky-Rabas","year":"2003","unstructured":"Kolominsky-Rabas PL, Hilz MJ, Neundoerfer B, Heuschmann PU: Impact of urinary incontinence after stroke: results from a prospective population-based stroke register. Neurourol Urodyn 2003, 22: 322\u2013327. 10.1002\/nau.10114","journal-title":"Neurourol Urodyn"},{"key":"1083_CR30","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1046\/j.1532-5415.2001.49242.x","volume":"49","author":"M Patel","year":"2001","unstructured":"Patel M, Coshall C, Lawrence E, Rudd AG, Wolfe CD: Recovery from poststroke urinary incontinence: associated factors and impact on outcome. J Am Geriatr Soc 2001, 49: 1229\u20131233. 10.1046\/j.1532-5415.2001.49242.x","journal-title":"J Am Geriatr Soc"},{"key":"1083_CR31","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1161\/01.STR.32.1.122","volume":"32","author":"M Patel","year":"2001","unstructured":"Patel M, Coshall C, Rudd AG, Wolfe CD: Natural history and effects on 2-year outcomes of urinary incontinence after stroke. Stroke 2001, 32: 122\u2013127. 10.1161\/01.STR.32.1.122","journal-title":"Stroke"},{"key":"1083_CR32","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s11136-006-0032-x","volume":"15","author":"JL Lemelle","year":"2006","unstructured":"Lemelle JL, Guillemin F, Aubert D, Guys JM, Lottmann H, Lortat-Jacob S, Mouriquand P, Ruffion A, Moscovici J, Schmitt M: Quality of life and continence in patients with spina bifida. Qual Life Res 2006, 15: 1481\u20131492. 10.1007\/s11136-006-0032-x","journal-title":"Qual Life Res"},{"key":"1083_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/nau.20079","volume":"24","author":"AR Morris","year":"2005","unstructured":"Morris AR, Ho MT, Lapsley H, Walsh J, Gonski P, Moore KH: Costs of managing urinary and faecal incontinence in a sub-acute care facility: a \u201cbottom-up\u201d approach. Neurourol Urodyn 2005, 24: 56\u201362. 10.1002\/nau.20079","journal-title":"Neurourol Urodyn"},{"key":"1083_CR34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.5694\/j.1326-5377.2003.tb05357.x","volume":"178","author":"JP Green","year":"2003","unstructured":"Green JP, Smoker I, Ho MT, Moore KH: Urinary incontinence in subacute care\u2013a retrospective analysis of clinical outcomes and costs. Med J Aust 2003, 178: 550\u2013553.","journal-title":"Med J Aust"},{"key":"1083_CR35","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.maturitas.2005.09.004","volume":"52 Suppl 2","author":"S Papanicolaou","year":"2005","unstructured":"Papanicolaou S, Pons ME, Hampel C, Monz B, Quail D, Schulenburg MG, Wagg A, Sykes D: Medical resource utilisation and cost of care for women seeking treatment for urinary incontinence in an outpatient setting. Examples from three countries participating in the PURE study. Maturitas 2005, 52 Suppl 2: S35-S47.","journal-title":"Maturitas"},{"key":"1083_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1464-410X.2008.08036.x","volume":"103","author":"DE Irwin","year":"2008","unstructured":"Irwin DE, Mungapen L, Milsom I, Kopp Z, Reeves P, Kelleher C: The economic impact of overactive bladder syndrome in six Western countries. BJU Int 2008, 103: 202\u2013209.","journal-title":"BJU Int"},{"key":"1083_CR37","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2165\/00019053-200017010-00005","volume":"17","author":"F Tediosi","year":"2000","unstructured":"Tediosi F, Parazzini F, Bortolotti A, Garattini L: The cost of urinary incontinence in Italian women. A cross-sectional study. Gruppo di Studio Incontinenza. Pharmacoeconomics 2000, 17: 71\u201376. 10.2165\/00019053-200017010-00005","journal-title":"Pharmacoeconomics"},{"key":"1083_CR38","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1097\/01.ju.0000155679.77895.cb","volume":"173","author":"DH Thom","year":"2005","unstructured":"Thom DH, Nygaard IE, Calhoun EA: Urologic diseases in America project: urinary incontinence in women-national trends in hospitalizations, office visits, treatment and economic impact. J Urol 2005, 173: 1295\u20131301. 10.1097\/01.ju.0000155679.77895.cb","journal-title":"J Urol"},{"key":"1083_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3928\/0098-9134-20030801-10","volume":"29","author":"RA Frantz","year":"2003","unstructured":"Frantz RA, Xakellis GC Jr, Harvey PC, Lewis AR: Implementing an incontinence management protocol in long-term care. Clinical outcomes and costs. J Gerontol Nurs 2003, 29: 46\u201353.","journal-title":"J Gerontol Nurs"},{"key":"1083_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0090-4295(03)00485-0","volume":"62","author":"YC Shih","year":"2003","unstructured":"Shih YC, Hartzema AG, Tolleson-Rinehart S: Labor costs associated with incontinence in long-term care facilities. Urology 2003, 62: 442\u2013446. 10.1016\/S0090-4295(03)00485-0","journal-title":"Urology"},{"key":"1083_CR41","first-page":"2316","volume":"90","author":"K Prasopsanti","year":"2007","unstructured":"Prasopsanti K, Santi-Ngamkun A, Pornprasit K: Estimated cost of overactive bladder in Thailand. J Med Assoc Thai 2007, 90: 2316\u20132320.","journal-title":"J Med Assoc Thai"},{"key":"1083_CR42","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/01.AOG.0000206213.48334.09","volume":"107","author":"LL Subak","year":"2006","unstructured":"Subak LL, Brown JS, Kraus SR, Brubaker L, Lin F, Richter HE, Bradley CS, Grady D: The \u201ccosts\u201d of urinary incontinence for women. Obstet Gynecol 2006, 107: 908\u2013916. 10.1097\/01.AOG.0000206213.48334.09","journal-title":"Obstet Gynecol"},{"key":"1083_CR43","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.juro.2009.12.029","volume":"183","author":"ST Mahajan","year":"2010","unstructured":"Mahajan ST, Patel PB, Marrie RA: Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry. J Urol 2010, 183: 1432\u20131437. 10.1016\/j.juro.2009.12.029","journal-title":"J Urol"},{"key":"1083_CR44","unstructured":"Atlas of MS Database. http:\/\/www.atlasofms.org\/index.aspx"},{"key":"1083_CR45","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1177\/135245859800400504","volume":"4","author":"K Whetten-Goldstein","year":"1998","unstructured":"Whetten-Goldstein K, Sloan FA, Goldstein LB, Kulas ED: A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult Scler 1998, 4: 419\u2013425.","journal-title":"Mult Scler"},{"key":"1083_CR46","volume-title":"Guidelines on Neurogenic Lower Urinary Tract Dysfunction","author":"M St\u00f6hrer","year":"2003","unstructured":"St\u00f6hrer M, Castro-Diaz D, Chartier-Kastler E, Kramer G, Mattiasson A, Wyndaele JJ: Guidelines on Neurogenic Lower Urinary Tract Dysfunction. Arnhem, the Netherlands: European Association of Urology (EAU); 2003."},{"key":"1083_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.clinthera.2005.01.006","volume":"27","author":"GG Kay","year":"2005","unstructured":"Kay GG, Granville LJ: Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly. Clin Ther 2005, 27: 127\u2013138. quiz 139\u2013140 10.1016\/j.clinthera.2005.01.006","journal-title":"Clin Ther"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7525-11-13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:45:01Z","timestamp":1630536301000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/1477-7525-11-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,31]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1083"],"URL":"https:\/\/doi.org\/10.1186\/1477-7525-11-13","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,31]]},"assertion":[{"value":"2 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"13"}}